Serum apolipoproteins are associated with systemic and retinal microvascular function in people with diabetes

Diabetes

Volumn 61, Issue 7, 2012, Pages 1785-1792

  Sasongko, Muhammad Bayu ^a,b   Wong, Tien Y ^a,c   Nguyen, Thanh T ^a   Kawasaki, Ryo ^a   Jenkins, Alicia J ^a   Shaw, Jonathan ^d   Robinson, Carol ^d   Wang, Jie Jin ^a,e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b GADJAH MADA UNIVERSITY   (Indonesia)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROPRUSSIDE SODIUM;

ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIABETIC PATIENT; DIABETIC RETINOPATHY; FEMALE; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; IONTOPHORESIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETINA ARTERY; VASODILATATION;

ACETYLCHOLINE; AGED; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; IONTOPHORESIS; LIGHT; LIPIDS; MALE; MICROVESSELS; MIDDLE AGED; NITROPRUSSIDE; RETINA; RETINAL VESSELS; SKIN;

EID: 84863228107     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-1272     Document Type: Article

References (39)

1. Sasongko MB, Wong TY, Nguyen TT, et al. Serum apolipoprotein AI and B are stronger biomarkers of diabetic retinopathy than traditional lipids. Diabetes Care 2011;34:474-479
2. Chait A, Montes VN. Apolipoproteins and diabetic retinopathy. Diabetes Care 2011;34:529-531
3. Ferré R, Aragonès G, Plana N, et al. High-density lipoprotein cholesterol and apolipoprotein A1 levels strongly influence the reactivity of small peripheral arteries. Atherosclerosis 2011;216:115-119
4. Curtis TM, Gardiner TA, Stitt AW. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye (Lond) 2009;23:1496-1508
5. Debbabi H, Bonnin P, Ducluzeau PH, Lefthériotis G, Levy BI. Noninvasive assessment of endothelial function in the skin microcirculation. Am J Hypertens 2010;23:541-546
6. Turner J, Belch JJ, Khan F. Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis. Trends Cardiovasc Med 2008;18:109-116 (Pubitemid 351802262)
7. Morris SJ, Shore AC. Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: possible mechanisms. J Physiol 1996;496:531-542 (Pubitemid 26370923)
8. Sasongko MB, Wang JJ, Donaghue KC, et al. Alterations in retinal microvascular geometry in young type 1 diabetes. Diabetes Care 2010;33:1331-1336
9. Sasongko MB, Wong TY, Nguyen TT, Cheung CY, Shaw JE, Wang JJ. Retinal vascular tortuosity in persons with diabetes and diabetic retinopathy. Diabetologia 2011;54:2409-2416
10. Sasongko MB, Wong TY, Donaghue KC, et al. Retinal arteriolar tortuosity is associated with retinopathy and early kidney dysfunction in type 1 diabetes. Am J Ophthalmol 2012;153:176.e1-183.e1
11. Nguyen TT, Kawasaki R, Wang JJ, et al. Flicker light-induced retinal vasodilation in diabetes and diabetic retinopathy. Diabetes Care 2009;32: 2075-2080
12. Nguyen TT, Shaw JE, Robinson C, et al. Diabetic retinopathy is related to both endothelium-dependent and -independent responses of skin microvascular flow. Diabetes Care 2011;34:1389-1393
13. van Hecke MV, Dekker JM, Nijpels G, et al. Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia 2005;48:1300-1306 (Pubitemid 41186094)
14. Nguyen TT, Kawasaki R, Kreis AJ, et al. Correlation of light-flicker-induced retinal vasodilation and retinal vascular caliber measurements in diabetes. Invest Ophthalmol Vis Sci 2009;50:5609-5613
15. Hart WE, Goldbaum M, Côté B, Kube P, Nelson MR. Measurement and classification of retinal vascular tortuosity. Int J Med Inform 1999;53:239-252 (Pubitemid 29101723)
16. Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy. Invest Ophthalmol Vis Sci 1981;21:210-226
17. Di Angelantonio E, Sarwar N, Perry P, et al.; Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009;302:1993-2000
18. McQueen MJ, Hawken S, Wang X, et al.; INTERHEART study investigators. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 2008;372:224-233 (Pubitemid 351978112)
19. Zeiher AM, Schächlinger V, Hohnloser SH, Saurbier B, Just H. Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation 1994;89:2525-2532
20. Dixon JL, Stoops JD, Parker JL, Laughlin MH, Weisman GA, Sturek M. Dyslipidemia and vascular dysfunction in diabetic pigs fed an atherogenic diet. Arterioscler Thromb Vasc Biol 1999;19:2981-2992 (Pubitemid 30029828)
21. Marcovina S, Packard CJ. Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels. J Intern Med 2006;259:437-446
22. Peterson SJ, Husney D, Kruger AL, et al. Long-term treatment with the apolipoprotein A1 mimetic peptide increases antioxidants and vascular repair in type I diabetic rats. J Pharmacol Exp Ther 2007;322:514-520 (Pubitemid 47105774)
23. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84:9265-9269
24. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526 (Pubitemid 17085822)
25. Dorner GT, Garhofer G, Kiss B, et al. Nitric oxide regulates retinal vascular tone in humans. Am J Physiol Heart Circ Physiol 2003;285:H631-H636 (Pubitemid 36885894)
26. Kondo M, Wang L, Bill A. The role of nitric oxide in hyperaemic response to flicker in the retina and optic nerve in cats. Acta Ophthalmol Scand 1997;75:232-235 (Pubitemid 27315582)
27. Goodfellow J, Ramsey MW, Luddington LA, et al. Endothelium and in-elastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetes. BMJ 1996;312:744-745
28. Jackson ZS, Dajnowiec D, Gotlieb AI, Langille BL. Partial off-loading of longitudinal tension induces arterial tortuosity. Arterioscler Thromb Vasc Biol 2005;25:957-962 (Pubitemid 40627839)
29. Kylstra JA, Wierzbicki T, Wolbarsht ML, Landers MB 3rd, Stefansson E. The relationship between retinal vessel tortuosity, diameter, and transmural pressure. Graefes Arch Clin Exp Ophthalmol 1986;224:477-480 (Pubitemid 16033885)
30. Shah PK, Kaul S, Nilsson J, Cercek B. Exploiting the vascular protective effects of high-density lipoprotein and its apolipoproteins: an idea whose time for testing is coming, part II. Circulation 2001;104:2498-2502 (Pubitemid 33108387)
31. Davidson MH. Apolipoprotein measurements: is more widespread use clinically indicated? Clin Cardiol 2009;32:482-486
32. Hill SA, McQueen MJ. Reverse cholesterol transport - a review of the process and its clinical implications. Clin Biochem 1997;30:517-525 (Pubitemid 27506075)
33. Johnson PC. Overview of the microcirculation. In Handbook of Physiology: Microcirculation. Tuma RF, Duran WN, Ley K, Eds. Amsterdam, Elsevier, 2008, p. 6-20
34. Chew EY, Ambrosius WT, Davis MD, et al.; ACCORD Study Group; ACCORD Eye Study Group. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010;363:233-244
35. Keech AC, Mitchell P, Summanen PA, et al.; FIELD study investigators. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet 2007;370:1687-1697 (Pubitemid 350100775)
36. Nguyen TT, Alibrahim E, Islam FM, et al. Inflammatory, hemostatic, and other novel biomarkers for diabetic retinopathy: the multi-ethnic study of atherosclerosis. Diabetes Care 2009;32:1704-1709
37. Cracowski JL, Minson CT, Salvat-Melis M, Halliwill JR. Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol Sci 2006;27:503-508 (Pubitemid 44233694)
38. Roosterman D, Goerge T, Schneider SW, Bunnett NW, Steinhoff M. Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev 2006;86:1309-1379 (Pubitemid 44523706)
39. Hiukka A, Maranghi M, Matikainen N, Taskinen MR. PPARalpha: an emerging therapeutic target in diabetic microvascular damage. Nat Rev Endocrinol 2010;6:454-463